Immediate Impact
60 standout
Citing Papers
GPCR drug discovery: new agents, targets and indications
2025 Standout
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
Works of Hristo Metev being referenced
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hristo Metev | 77 | 79 | 129 | 125 | 4 | 268 | |
| Amy S. Feldman | 120 | 121 | 131 | 75 | 4 | 310 | |
| Sarah Dudley | 96 | 79 | 146 | 100 | 4 | 260 | |
| Diana Raedler | 63 | 34 | 163 | 177 | 6 | 322 | |
| Hemalini Mehta | 69 | 54 | 51 | 58 | 5 | 238 | |
| Richard McKendry | 79 | 45 | 80 | 92 | 7 | 292 | |
| X. Charlene Liao | 42 | 115 | 124 | 84 | 7 | 325 | |
| Giulia Gnesini | 140 | 53 | 150 | 72 | 6 | 284 | |
| Richard Brooker | 166 | 71 | 100 | 42 | 7 | 268 | |
| Paula R. Kroening | 87 | 33 | 77 | 164 | 3 | 331 | |
| Laura S. Christian | 130 | 26 | 181 | 156 | 5 | 335 |
All Works
Loading papers...